| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,952 |
1,939 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
88 |
83 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,664 |
1,559 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,991 |
3,544 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,090 |
1,914 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,463 |
1,125 |
$0.00 |
| 99441 |
|
904 |
861 |
$0.00 |
| 3075F |
|
99 |
97 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
72 |
70 |
$0.00 |
| 85027 |
|
71 |
67 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
327 |
324 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
70 |
69 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
278 |
274 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
286 |
284 |
$0.00 |
| 1220F |
|
414 |
407 |
$0.00 |
| 3074F |
|
377 |
339 |
$0.00 |
| 82607 |
|
12 |
12 |
$0.00 |
| 3079F |
|
161 |
157 |
$0.00 |
| 90656 |
|
18 |
18 |
$0.00 |
| 3044F |
|
231 |
228 |
$0.00 |
| 86780 |
|
107 |
107 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
74 |
69 |
$0.00 |
| 82043 |
|
116 |
113 |
$0.00 |
| 81001 |
|
27 |
26 |
$0.00 |
| 1111F |
|
151 |
139 |
$0.00 |
| 3080F |
|
27 |
27 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$0.00 |
| 87340 |
|
18 |
18 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19 |
18 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20 |
13 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,114 |
926 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,592 |
1,345 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
338 |
336 |
$0.00 |
| 82274 |
|
130 |
130 |
$0.00 |
| 99442 |
|
631 |
606 |
$0.00 |
| 80061 |
Lipid panel |
1,699 |
1,686 |
$0.00 |
| 82540 |
|
116 |
113 |
$0.00 |
| 3078F |
|
382 |
337 |
$0.00 |
| 86703 |
|
247 |
247 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
64 |
28 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
70 |
69 |
$0.00 |
| 3077F |
|
82 |
74 |
$0.00 |
| 84100 |
|
12 |
12 |
$0.00 |
| 1033F |
|
40 |
40 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
18 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$0.00 |